Loading…

Structural mapping of the active site specificity determinants of human tissue-type plasminogen activator. Implications for the design of low molecular weight substrates and inhibitors

The recent structure determination of the catalytic domain of tissue-type plasminogen activator (tPA) suggested residue Arg174 could play a role in P3/P4 substrate specificity. Six synthetic chromogenic tPA substrates of the type R-Xaa-Gly-Arg-p-nitroanilide, in which R is an N-terminal protection g...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of biological chemistry 1997-08, Vol.272 (35), p.21713-21719
Main Authors: Renatus, M, Bode, W, Huber, R, Stürzebecher, J, Prasa, D, Fischer, S, Kohnert, U, Stubbs, M T
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 21719
container_issue 35
container_start_page 21713
container_title The Journal of biological chemistry
container_volume 272
creator Renatus, M
Bode, W
Huber, R
Stürzebecher, J
Prasa, D
Fischer, S
Kohnert, U
Stubbs, M T
description The recent structure determination of the catalytic domain of tissue-type plasminogen activator (tPA) suggested residue Arg174 could play a role in P3/P4 substrate specificity. Six synthetic chromogenic tPA substrates of the type R-Xaa-Gly-Arg-p-nitroanilide, in which R is an N-terminal protection group, were synthesized to test this property. Although changing the residue Xaa (in its L or D form) at position P3 from the hydrophobic Phe to an acidic residue, Asp or Glu, gave no improvement in catalytic efficiency, comparative analysis of the substrates indicated a preference for an acidic substituent occupying the S3 site when the S4 site contains a hydrophobic or basic moiety. The 2.9 A structure determination of the catalytic domain of human tPA in complex with the bis-benzamidine inhibitor 2, 7-bis-(4-amidinobenzylidene)-cycloheptan-1-one reveals a three-site interaction, salt bridge formation of the proximal amidino group of the inhibitor with Asp189 in the primary specificity pocket, extensive hydrophobic surface burial, and a weak electrostatic interaction between the distal amidino group of the inhibitor and two carbonyl oxygens of the protein. The latter position was previously occupied by the guanidino group of Arg174, which swings out to form the western edge of the S3 pocket. These data suggest that the side chain of Arg174 is flexible, and does not play a major role in the S4 specificity of tPA. On the other hand, this residue would modulate S3 specificity, and may be exploited to fine tune the specificity and selectivity of tPA substrates and inhibitors.
doi_str_mv 10.1074/jbc.272.35.21713
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_79232694</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>79232694</sourcerecordid><originalsourceid>FETCH-LOGICAL-p206t-75d00817afa1f55d92a601dab3d3b0e9f4129b7610b8f5e78d1d1bd802fe2ce33</originalsourceid><addsrcrecordid>eNotkDtvFDEUhV0EhRDoaSK5opuJ7dl5uEQRj0iRKIB6dW1f7zry2MYPov1n_Dwmyd7inObTd6RLyEfOes7m3e2j0r2YRT-MveAzHy7IFWOCd1KMy1vyrpRHtt1O8ktyKcW0CCmvyL-fNTddWwZPV0jJhQONltYjUtDV_UVaXN0ioXbWaVdP1GDFvLoAoZZn9thWCLS6Uhp29ZSQJg9lA-IBw6sFasw9vV-Tdxqqi6FQG_PLisHiDuHZ4-MTXaNH3Txk-oTucKy0NFVqhoqFQjDUhaNTbrOV9-SNBV_ww7mvye-vX37dfe8efny7v_v80CXBptrNo2Fs4TNY4HYcjRQwMW5ADWZQDKXdcSHVPHGmFjvivBhuuDILExaFxmG4Jp9evSnHPw1L3a-uaPQeAsZW9rMUg5jkbgNvzmBTK5p9ym6FfNqfXz38B5lzhXM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>79232694</pqid></control><display><type>article</type><title>Structural mapping of the active site specificity determinants of human tissue-type plasminogen activator. Implications for the design of low molecular weight substrates and inhibitors</title><source>ScienceDirect</source><creator>Renatus, M ; Bode, W ; Huber, R ; Stürzebecher, J ; Prasa, D ; Fischer, S ; Kohnert, U ; Stubbs, M T</creator><creatorcontrib>Renatus, M ; Bode, W ; Huber, R ; Stürzebecher, J ; Prasa, D ; Fischer, S ; Kohnert, U ; Stubbs, M T</creatorcontrib><description>The recent structure determination of the catalytic domain of tissue-type plasminogen activator (tPA) suggested residue Arg174 could play a role in P3/P4 substrate specificity. Six synthetic chromogenic tPA substrates of the type R-Xaa-Gly-Arg-p-nitroanilide, in which R is an N-terminal protection group, were synthesized to test this property. Although changing the residue Xaa (in its L or D form) at position P3 from the hydrophobic Phe to an acidic residue, Asp or Glu, gave no improvement in catalytic efficiency, comparative analysis of the substrates indicated a preference for an acidic substituent occupying the S3 site when the S4 site contains a hydrophobic or basic moiety. The 2.9 A structure determination of the catalytic domain of human tPA in complex with the bis-benzamidine inhibitor 2, 7-bis-(4-amidinobenzylidene)-cycloheptan-1-one reveals a three-site interaction, salt bridge formation of the proximal amidino group of the inhibitor with Asp189 in the primary specificity pocket, extensive hydrophobic surface burial, and a weak electrostatic interaction between the distal amidino group of the inhibitor and two carbonyl oxygens of the protein. The latter position was previously occupied by the guanidino group of Arg174, which swings out to form the western edge of the S3 pocket. These data suggest that the side chain of Arg174 is flexible, and does not play a major role in the S4 specificity of tPA. On the other hand, this residue would modulate S3 specificity, and may be exploited to fine tune the specificity and selectivity of tPA substrates and inhibitors.</description><identifier>ISSN: 0021-9258</identifier><identifier>DOI: 10.1074/jbc.272.35.21713</identifier><identifier>PMID: 9268299</identifier><language>eng</language><publisher>United States</publisher><subject>Arginine - metabolism ; Binding Sites ; Catalysis ; Enzyme Inhibitors - chemical synthesis ; Enzyme Inhibitors - metabolism ; Humans ; Kinetics ; Models, Chemical ; Models, Molecular ; Peptide Mapping ; Structure-Activity Relationship ; Substrate Specificity ; Tissue Plasminogen Activator - antagonists &amp; inhibitors ; Tissue Plasminogen Activator - chemistry ; Tissue Plasminogen Activator - metabolism</subject><ispartof>The Journal of biological chemistry, 1997-08, Vol.272 (35), p.21713-21719</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9268299$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Renatus, M</creatorcontrib><creatorcontrib>Bode, W</creatorcontrib><creatorcontrib>Huber, R</creatorcontrib><creatorcontrib>Stürzebecher, J</creatorcontrib><creatorcontrib>Prasa, D</creatorcontrib><creatorcontrib>Fischer, S</creatorcontrib><creatorcontrib>Kohnert, U</creatorcontrib><creatorcontrib>Stubbs, M T</creatorcontrib><title>Structural mapping of the active site specificity determinants of human tissue-type plasminogen activator. Implications for the design of low molecular weight substrates and inhibitors</title><title>The Journal of biological chemistry</title><addtitle>J Biol Chem</addtitle><description>The recent structure determination of the catalytic domain of tissue-type plasminogen activator (tPA) suggested residue Arg174 could play a role in P3/P4 substrate specificity. Six synthetic chromogenic tPA substrates of the type R-Xaa-Gly-Arg-p-nitroanilide, in which R is an N-terminal protection group, were synthesized to test this property. Although changing the residue Xaa (in its L or D form) at position P3 from the hydrophobic Phe to an acidic residue, Asp or Glu, gave no improvement in catalytic efficiency, comparative analysis of the substrates indicated a preference for an acidic substituent occupying the S3 site when the S4 site contains a hydrophobic or basic moiety. The 2.9 A structure determination of the catalytic domain of human tPA in complex with the bis-benzamidine inhibitor 2, 7-bis-(4-amidinobenzylidene)-cycloheptan-1-one reveals a three-site interaction, salt bridge formation of the proximal amidino group of the inhibitor with Asp189 in the primary specificity pocket, extensive hydrophobic surface burial, and a weak electrostatic interaction between the distal amidino group of the inhibitor and two carbonyl oxygens of the protein. The latter position was previously occupied by the guanidino group of Arg174, which swings out to form the western edge of the S3 pocket. These data suggest that the side chain of Arg174 is flexible, and does not play a major role in the S4 specificity of tPA. On the other hand, this residue would modulate S3 specificity, and may be exploited to fine tune the specificity and selectivity of tPA substrates and inhibitors.</description><subject>Arginine - metabolism</subject><subject>Binding Sites</subject><subject>Catalysis</subject><subject>Enzyme Inhibitors - chemical synthesis</subject><subject>Enzyme Inhibitors - metabolism</subject><subject>Humans</subject><subject>Kinetics</subject><subject>Models, Chemical</subject><subject>Models, Molecular</subject><subject>Peptide Mapping</subject><subject>Structure-Activity Relationship</subject><subject>Substrate Specificity</subject><subject>Tissue Plasminogen Activator - antagonists &amp; inhibitors</subject><subject>Tissue Plasminogen Activator - chemistry</subject><subject>Tissue Plasminogen Activator - metabolism</subject><issn>0021-9258</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><recordid>eNotkDtvFDEUhV0EhRDoaSK5opuJ7dl5uEQRj0iRKIB6dW1f7zry2MYPov1n_Dwmyd7inObTd6RLyEfOes7m3e2j0r2YRT-MveAzHy7IFWOCd1KMy1vyrpRHtt1O8ktyKcW0CCmvyL-fNTddWwZPV0jJhQONltYjUtDV_UVaXN0ioXbWaVdP1GDFvLoAoZZn9thWCLS6Uhp29ZSQJg9lA-IBw6sFasw9vV-Tdxqqi6FQG_PLisHiDuHZ4-MTXaNH3Txk-oTucKy0NFVqhoqFQjDUhaNTbrOV9-SNBV_ww7mvye-vX37dfe8efny7v_v80CXBptrNo2Fs4TNY4HYcjRQwMW5ADWZQDKXdcSHVPHGmFjvivBhuuDILExaFxmG4Jp9evSnHPw1L3a-uaPQeAsZW9rMUg5jkbgNvzmBTK5p9ym6FfNqfXz38B5lzhXM</recordid><startdate>19970829</startdate><enddate>19970829</enddate><creator>Renatus, M</creator><creator>Bode, W</creator><creator>Huber, R</creator><creator>Stürzebecher, J</creator><creator>Prasa, D</creator><creator>Fischer, S</creator><creator>Kohnert, U</creator><creator>Stubbs, M T</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>19970829</creationdate><title>Structural mapping of the active site specificity determinants of human tissue-type plasminogen activator. Implications for the design of low molecular weight substrates and inhibitors</title><author>Renatus, M ; Bode, W ; Huber, R ; Stürzebecher, J ; Prasa, D ; Fischer, S ; Kohnert, U ; Stubbs, M T</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p206t-75d00817afa1f55d92a601dab3d3b0e9f4129b7610b8f5e78d1d1bd802fe2ce33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Arginine - metabolism</topic><topic>Binding Sites</topic><topic>Catalysis</topic><topic>Enzyme Inhibitors - chemical synthesis</topic><topic>Enzyme Inhibitors - metabolism</topic><topic>Humans</topic><topic>Kinetics</topic><topic>Models, Chemical</topic><topic>Models, Molecular</topic><topic>Peptide Mapping</topic><topic>Structure-Activity Relationship</topic><topic>Substrate Specificity</topic><topic>Tissue Plasminogen Activator - antagonists &amp; inhibitors</topic><topic>Tissue Plasminogen Activator - chemistry</topic><topic>Tissue Plasminogen Activator - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Renatus, M</creatorcontrib><creatorcontrib>Bode, W</creatorcontrib><creatorcontrib>Huber, R</creatorcontrib><creatorcontrib>Stürzebecher, J</creatorcontrib><creatorcontrib>Prasa, D</creatorcontrib><creatorcontrib>Fischer, S</creatorcontrib><creatorcontrib>Kohnert, U</creatorcontrib><creatorcontrib>Stubbs, M T</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of biological chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Renatus, M</au><au>Bode, W</au><au>Huber, R</au><au>Stürzebecher, J</au><au>Prasa, D</au><au>Fischer, S</au><au>Kohnert, U</au><au>Stubbs, M T</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Structural mapping of the active site specificity determinants of human tissue-type plasminogen activator. Implications for the design of low molecular weight substrates and inhibitors</atitle><jtitle>The Journal of biological chemistry</jtitle><addtitle>J Biol Chem</addtitle><date>1997-08-29</date><risdate>1997</risdate><volume>272</volume><issue>35</issue><spage>21713</spage><epage>21719</epage><pages>21713-21719</pages><issn>0021-9258</issn><abstract>The recent structure determination of the catalytic domain of tissue-type plasminogen activator (tPA) suggested residue Arg174 could play a role in P3/P4 substrate specificity. Six synthetic chromogenic tPA substrates of the type R-Xaa-Gly-Arg-p-nitroanilide, in which R is an N-terminal protection group, were synthesized to test this property. Although changing the residue Xaa (in its L or D form) at position P3 from the hydrophobic Phe to an acidic residue, Asp or Glu, gave no improvement in catalytic efficiency, comparative analysis of the substrates indicated a preference for an acidic substituent occupying the S3 site when the S4 site contains a hydrophobic or basic moiety. The 2.9 A structure determination of the catalytic domain of human tPA in complex with the bis-benzamidine inhibitor 2, 7-bis-(4-amidinobenzylidene)-cycloheptan-1-one reveals a three-site interaction, salt bridge formation of the proximal amidino group of the inhibitor with Asp189 in the primary specificity pocket, extensive hydrophobic surface burial, and a weak electrostatic interaction between the distal amidino group of the inhibitor and two carbonyl oxygens of the protein. The latter position was previously occupied by the guanidino group of Arg174, which swings out to form the western edge of the S3 pocket. These data suggest that the side chain of Arg174 is flexible, and does not play a major role in the S4 specificity of tPA. On the other hand, this residue would modulate S3 specificity, and may be exploited to fine tune the specificity and selectivity of tPA substrates and inhibitors.</abstract><cop>United States</cop><pmid>9268299</pmid><doi>10.1074/jbc.272.35.21713</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0021-9258
ispartof The Journal of biological chemistry, 1997-08, Vol.272 (35), p.21713-21719
issn 0021-9258
language eng
recordid cdi_proquest_miscellaneous_79232694
source ScienceDirect
subjects Arginine - metabolism
Binding Sites
Catalysis
Enzyme Inhibitors - chemical synthesis
Enzyme Inhibitors - metabolism
Humans
Kinetics
Models, Chemical
Models, Molecular
Peptide Mapping
Structure-Activity Relationship
Substrate Specificity
Tissue Plasminogen Activator - antagonists & inhibitors
Tissue Plasminogen Activator - chemistry
Tissue Plasminogen Activator - metabolism
title Structural mapping of the active site specificity determinants of human tissue-type plasminogen activator. Implications for the design of low molecular weight substrates and inhibitors
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-23T20%3A07%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Structural%20mapping%20of%20the%20active%20site%20specificity%20determinants%20of%20human%20tissue-type%20plasminogen%20activator.%20Implications%20for%20the%20design%20of%20low%20molecular%20weight%20substrates%20and%20inhibitors&rft.jtitle=The%20Journal%20of%20biological%20chemistry&rft.au=Renatus,%20M&rft.date=1997-08-29&rft.volume=272&rft.issue=35&rft.spage=21713&rft.epage=21719&rft.pages=21713-21719&rft.issn=0021-9258&rft_id=info:doi/10.1074/jbc.272.35.21713&rft_dat=%3Cproquest_pubme%3E79232694%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p206t-75d00817afa1f55d92a601dab3d3b0e9f4129b7610b8f5e78d1d1bd802fe2ce33%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=79232694&rft_id=info:pmid/9268299&rfr_iscdi=true